<DOC>
	<DOCNO>NCT02035657</DOCNO>
	<brief_summary>This single arm , open-label , single center study evaluate safety , feasibility , clinical efficacy immunogenicity GLA-SE administration patient Merkel cell carcinoma . Ten patient treat . The goal GLA-SE assist patient 's immune system attack cancer cell .</brief_summary>
	<brief_title>A Proof-of-Concept Trial GLA-SE Patients With Merkel Cell Carcinoma</brief_title>
	<detailed_description>This single arm , open-label , single center study evaluate safety , feasibility , clinical efficacy immunogenicity GLA-SE administration patient Merkel cell carcinoma . Ten patient metastatic locoregional disease treat . The goal GLA-SE assist patient 's immune system attack cancer cell .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Merkel Cell</mesh_term>
	<criteria>Biopsyconfirmed Merkel cell carcinoma metastatic locoregional disease . Patients must least one injectable lesion , define easily palpable superficial lesion ( cutaneous , subcutaneous lymph nodal metastasis ) accurately localize , stabilize palpation , superficial enough enable IT injection . ECOG performance status score 0 , 1 2 ≥ 18 year age Life expectancy ≥ three month . Adequate neutrophil platelet count Adequate renal hepatic function Willing undergo pretreatment lesion biopsy posttreatment lesion biopsy Use effective contraception Signed informed consent document Members gender , race ethnic group eligible trial Prior chemotherapy major surgical procedure within 3 week , radiotherapy within 2 week prior first study treatment No concurrent anticancer treatment ( include topical agent imiquimod ) investigational agent Active , untreated brain metastasis Pregnant nursing Use systemic immunosuppressive agent Immunosuppressed patient Uncontrolled depression major psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Merkel cell carcinoma</keyword>
	<keyword>MCC</keyword>
</DOC>